Gabriella Halm

Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations

Hajnalka Andrikovics, Tünde Krähling, Katalin Balassa et al. · Haematologica · 2014 · 98 citations · Full text

Medicine, Genetics, Molecular Genetics +14

Additional Chromosome Abnormalities, BCR-ABL Tyrosine Kinase Domain Mutations and Clinical Outcome in Hungarian Tyrosine Kinase Inhibitor-Resistant Chronic Myelogenous Leukemia Patients

Nóra Meggyesi, András Kozma, Gabriella Halm et al. · Acta Haematologica · 2011 · 30 citations

Life Sciences, Genetics, Hematology +17

Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common <i>TERT</i> Polymorphism rs2736100

Tünde Krähling, Katalin Balassa, Katalin Piroska Kiss et al. · Cancer Epidemiology Biomarkers & Prevention · 2015 · 24 citations

Medicine, Genetics, Oncology +13

<i>HFE</i>C282Y Mutation as a Genetic Modifier Influencing Disease Susceptibility for Chronic Myeloproliferative Disease

Hajnalka Andrikovics, Nóra Meggyesi, Anikó Szilvási et al. · Cancer Epidemiology Biomarkers & Prevention · 2009 · 14 citations · Full text

Medicine, Genetics, Hematology +12

Simultaneous proteosome inhibition and heat shock protein induction by bortezomib is beneficial in experimental pancreatitis

Annamária Szabolcs, György Biczó, Zoltán Rakonczay et al. · European Journal of Pharmacology · 2009 · 13 citations

Life Sciences, Biochemistry, Molecular Biology +12